ATE207343T1 - O-carboxymethylchitosan enthaltende mittel und ihre verwendung in ophthalmika - Google Patents

O-carboxymethylchitosan enthaltende mittel und ihre verwendung in ophthalmika

Info

Publication number
ATE207343T1
ATE207343T1 AT96928418T AT96928418T ATE207343T1 AT E207343 T1 ATE207343 T1 AT E207343T1 AT 96928418 T AT96928418 T AT 96928418T AT 96928418 T AT96928418 T AT 96928418T AT E207343 T1 ATE207343 T1 AT E207343T1
Authority
AT
Austria
Prior art keywords
polysaccharide
solution
carboxymethylchitosan
ophthalmics
agents containing
Prior art date
Application number
AT96928418T
Other languages
English (en)
Inventor
Kenneth W Reed
Shau-Fong Yen
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE207343T1 publication Critical patent/ATE207343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96928418T 1995-08-17 1996-08-06 O-carboxymethylchitosan enthaltende mittel und ihre verwendung in ophthalmika ATE207343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51642095A 1995-08-17 1995-08-17
PCT/EP1996/003477 WO1997006782A1 (en) 1995-08-17 1996-08-06 Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics

Publications (1)

Publication Number Publication Date
ATE207343T1 true ATE207343T1 (de) 2001-11-15

Family

ID=24055505

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928418T ATE207343T1 (de) 1995-08-17 1996-08-06 O-carboxymethylchitosan enthaltende mittel und ihre verwendung in ophthalmika

Country Status (11)

Country Link
US (1) US5773608A (de)
EP (1) EP0844868B1 (de)
JP (1) JPH11510497A (de)
AT (1) ATE207343T1 (de)
AU (1) AU6789796A (de)
DE (1) DE69616347T2 (de)
DK (1) DK0844868T3 (de)
ES (1) ES2166905T3 (de)
PT (1) PT844868E (de)
TW (1) TW389694B (de)
WO (1) WO1997006782A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19617019A1 (de) 1996-04-27 1997-11-06 Beiersdorf Ag Alkyl-2-acetamino-2-desoxy-glucopyranosid-uronsäuren und -Derivate, ihre Herstellung sowie ihre Verwendung als Tenside in kosmetischen und pharmazeutischen Zubereitungen
DK0893121T3 (da) * 1997-06-27 2002-06-17 Akzo Nobel Nv Flydende oral medicinopløsning
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
BR9912627A (pt) 1998-07-30 2002-02-13 Nutriceuticals Inc E Composição em suspensão lìquida estável, e, processos para preparação e uso da mesma e para tratamento de peso e de colesterol
WO2001000044A1 (en) * 1999-06-25 2001-01-04 E-Nutriceuticals, Inc. Novel chitosan-containing liquid compositions and methods for their preparation and use
US6537584B1 (en) * 1999-11-12 2003-03-25 Macromed, Inc. Polymer blends that swell in an acidic environment and deswell in a basic environment
EP1240230B1 (de) * 1999-11-12 2006-03-01 MacroMed, Inc. An- und abschwellende polymermischungen
DK1229940T3 (da) * 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
IL153490A0 (en) * 2000-06-29 2003-07-06 Biosyntech Canada Inc Composition and method for the repair and regeneration of cartilage and other tissues
AU2001288120A1 (en) * 2000-09-26 2002-04-08 Kyorin Pharmaceutical Co. Ltd. Liquid prednisolone sodium phosphate preparation
WO2002040070A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
ATE481110T1 (de) * 2002-07-16 2010-10-15 Biosyntech Canada Inc Zusammensetzung für die herstellung zellkompatibler, injizierbarer, selbstgelierender chitosan lösungen zum einkapseln und verabreichen von lebenden zellen oderbiologisch aktiven faktoren
US6896809B2 (en) * 2002-12-20 2005-05-24 Providence Health System - Oregon Methods for purifying chitosan
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
EP1727525A4 (de) * 2004-03-23 2009-12-09 Lytone Enterprise Inc In chitosan eingebettete oder verkapselte kapsel
EP1787643A1 (de) * 2004-09-09 2007-05-23 Jimenez Bayardo, Arturo Implantat und mikrokugeln zur dauerhaften abgabe von medikamenten zur ophthalmischen anwendung und herstellungsverfahren dafür
ATE533491T1 (de) * 2004-09-21 2011-12-15 Trobio Ab Stabilisierte protease zusammensetzungen enthaltend eine serinprotease, morpholin-derivate und reversible serinprotease- inhibitoren
EP1945712A4 (de) * 2005-11-04 2013-05-01 Piramal Healthcare Canada Ltd Gelbindung von wässrigen polyelektrolytlösungen durch thermisch induzierte änderungen des ionisationszustands
CN100572388C (zh) * 2005-12-14 2009-12-23 河南省科学院河南省发展计划委员会地理研究所 乙酰水杨酸与壳聚糖-2，6位接枝物制备方法
PL1978925T3 (pl) * 2005-12-23 2010-01-29 Laboratoire Medidom S A Termoutwardzalna zobojętniona kompozycja chitozanu tworząca hydrożel, liofilizat i sposoby ich wytwarzania
BRPI0807065A2 (pt) * 2007-01-31 2017-03-21 Allergan Inc biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos
KR20180123727A (ko) * 2012-01-20 2018-11-19 임무노포토닉스 인코퍼레이티드 키토산 유래 조성물
US11773188B2 (en) 2012-01-20 2023-10-03 Immunophotonics, Inc Chitosan-derived compositions
US20190002594A1 (en) 2014-07-16 2019-01-03 Immunophotonics, Inc. Chitosan-Derived Compositions
CA3019436A1 (en) 2016-03-30 2017-10-05 Qualizyme Diagnostics Gmbh & Co Kg Detecting microbial infection in wounds
PT3500255T (pt) * 2016-08-19 2023-01-10 Orasis Pharmaceuticals Ltd Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
CN109260145B (zh) * 2018-10-09 2020-12-22 湖北远大天天明制药有限公司 含有珍珠层粉可舒缓眼部疲劳的滴眼液组合物、制备方法与用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386151A (en) * 1981-06-26 1983-05-31 Polaroid Corporation Diffusion transfer film system with protective layer of copper salt, chitosan and selected polyols
DE3440444A1 (de) * 1984-11-06 1986-05-07 Dechema Deutsche Gesellschaft für chemisches Apparatewesen e.V., 6000 Frankfurt Verfahren zur herstellung grob gekoernter schichtsilikate und deren verwendung als adsorbentien fuer proteine
GB8520085D0 (en) * 1985-08-09 1985-09-18 British Food Mfg Ind Res Foamed food products
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
IT1190347B (it) * 1986-06-16 1988-02-16 Franco Conti Processo per la preparazione dell'n-dimetilchitosano e suoi impieghi farmacologici
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US5550187A (en) * 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
DE69015775T2 (de) * 1989-10-31 1995-05-11 Howmedica Chitinderivate enthaltende Zusammensetzungen zur Verhütung der Adhäsion.
US5204452A (en) * 1990-11-14 1993-04-20 E. I. Du Pont De Nemours And Company N-halochitosans, their preparation and uses
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
CA2074424A1 (en) * 1992-07-22 1994-01-23 Bryce L. Fanning Acoustic gel
WO1994007999A1 (en) * 1992-09-28 1994-04-14 Brown University Research Foundation Chitosan matrices for encapsulated cells
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
EP0665022A1 (de) * 1994-01-28 1995-08-02 Prodex, Inc. Viskoelastische Lösung aus N,O-Carboxymethylchitosan zur opthalmischen Verwendung
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
DE69616347D1 (de) 2001-11-29
WO1997006782A1 (en) 1997-02-27
DK0844868T3 (da) 2002-01-28
US5773608A (en) 1998-06-30
PT844868E (pt) 2002-03-28
EP0844868A1 (de) 1998-06-03
AU6789796A (en) 1997-03-12
ES2166905T3 (es) 2002-05-01
JPH11510497A (ja) 1999-09-14
EP0844868B1 (de) 2001-10-24
DE69616347T2 (de) 2002-07-04
TW389694B (en) 2000-05-11

Similar Documents

Publication Publication Date Title
ATE207343T1 (de) O-carboxymethylchitosan enthaltende mittel und ihre verwendung in ophthalmika
BR9907679A (pt) Complexo estéril de peptìdio terapêutico ligado a um polissacarìdeo
AU1617897A (en) Ophthalmic solutions viscosified with tamarind seed polysaccharide
MY124122A (en) Heterocyclic derivatives
CA2146938A1 (en) Method of Controlling Structure Stability of Collagen Fibers Produced from Solutions or Dispersions Treated with Sodium Hydroxide for Infectious Agent Deactivation
AU5274996A (en) Nanospheres comprising a biocompatible polysaccharide
CA2177823A1 (en) Poly-beta-1-->4-n-acetylglucosamine
DE50011218D1 (de) Verwendung von nanoskaligen sterolen und sterolestern
IL142066A0 (en) Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
TW255883B (de)
CA2161774A1 (en) Synthetic viscoelastic material for ophthalmic applications
CZ16395A3 (en) Inclusion complexes of nimesulid salts of alkali metals and alkaline earth metals with cyclodextrins, process of their preparation and pharmaceutical compositions containing thereof
HUT57205A (en) Process for producing cycloalkano/b/-indol derivatives and pharmaceutical compositions containing them
IE831920L (en) 2,4-diamino-5-piperazinyl pyrimidines
DK0469953T3 (da) Komposition omfattende en succinoglycan
WO1997007139A3 (en) Stabilized chitin derivative compounds
EP0475383A3 (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
CA2048055A1 (fr) Composition comportant un polysaccharide obtenu par fermentation microbienne
NO20005492L (no) Dekstrinholdig preparat for prevensjon av kirurgiske adhesjoner
PL347735A1 (en) Antibacterial aqueous ophthalmic solution containing ofloxacin and application of chitosane for solubilising ofloxacin dispersed in an aqueous solution
HUP9802706A2 (hu) Eljárás vérlemezkék mikrobiológiai szennyeződésének inaktiválására
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung
AU5269696A (en) Anellated beta-carbolines
CA2235967A1 (en) Diarylethylene metallocene derivatives, their processes of preparation and pharmaceutical compositions containing said derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee